Choosing best laboratory practice
•Download as PPT, PDF•
0 likes•352 views
The document discusses standard laboratory practices and standard operating procedures (SOPs) developed by the Health Protection Agency (HPA) in the UK. It provides an overview of the HPA's Standards and Evaluations units, which develop SOPs for clinical microbiology laboratories. It also discusses feedback from a survey of laboratories on the SOP for investigating genital tract specimens, including which aspects they found useful and suggestions for improvement. The talk concludes with plans to develop a new SOP for screening group B streptococcus from genital swabs.
Report
Share
Report
Share
![Choosing Best Laboratory Practice Valerie Bevan Jerry Skinner Ruhi Siddiqui Janet Norcup Sam Gillanders www.HPA.org.uk www.evaluations-standards.org.uk [email_address] standardsunit @HPA.org. uk 14 May 2004](https://image.slidesharecdn.com/choosingbestlaboratorypractice-120203073507-phpapp02/85/Choosing-best-laboratory-practice-1-320.jpg)
![Today’s talk ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Developing a Test for COVID-19 at Michigan Medicine
Developing a Test for COVID-19 at Michigan MedicineUniversity of Michigan Department of Emergency Medicine
This document summarizes the development of COVID-19 testing at Michigan Medicine. It discusses the process of obtaining FDA approval or emergency use authorization for tests, challenges in developing and validating new tests, and lessons learned from expanding testing capacity. Initial efforts focused on verifying and validating tests from CDC protocols and commercial vendors. Over time, testing was expanded to more patients using high-throughput and rapid turnaround time assays. Challenges included shortages of collection kits and regulatory barriers, while lessons highlighted the need for better integration between clinical labs, public health, and industry in response to emerging diseases.Driving Point of Care Technology Development: Integrated Approach to Consensu...
The WALEX process combines facilitated discussion and discrete choice experiments to define the attributes of a realistic point-of-care test for Chlamydia trachomatis. Key findings include:
1) Participants were willing to accept longer test times and slightly higher instrument costs to preserve attributes like lower test cost, vaginal sample type, and processing multiple samples per batch.
2) Analysis of survey data identified where participants were willing to compromise on attributes and where they were unwilling.
3) The methodology provides a way to understand user needs and tradeoffs to help bridge the gap between need and realization of new diagnostic technologies.
Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisse...
Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisse...National Chlamydia Coalition
Presented by John R. Papp, Senior Service Fellow, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, at the 2010 National Chlamydia Coalition meetingM tyagi resume 2019
This document provides a summary of the qualifications and experience of Manoj Tyagi, Ph.D. He has over 15 years of experience in quality management, regulatory compliance, and laboratory accreditation. Currently he serves as the Chief Scientific Officer and Laboratory Director of Captiva Lab LLC, where he oversees CLIA and accreditation compliance. He has extensive expertise in clinical chemistry, toxicology, and workplace drug testing.
Diagnostic Testing Conference 2020
The Diagnostic & Testing virtual conference held on the 11th June 2020 was an inspiring event examining the role of both molecular and rapid diagnostics in tackling disease, infection and reducing the impact of COVID-19 within our communities and hospitals. The virtual conference explored how health professionals, academics and industry are driving diagnostic and testing usage within laboratories, pharmacies and community practice.
The conference built upon the UK Diagnostics Summit held annually in London discussed how diagnostics and testing are tackling COVID-19, the technology in development, accuracy of COVID-19 tests as well as exploring current testing methods for cancer, diabetes, sepsis, urinary tract infections and HAI’S.
Advanced In-Office 1-hour PCR LAB - Ancillary Revenue Program
Advanced In-Office 1-hour PCR LAB - Ancillary Revenue ProgramOptimal Health Advocates-Ancillary Revenue Generation Specialists
Ancillary Revenue Program - Are you still sending out these tests to an outside lab? UTI/STI • Vaginitis • Respiratory • ENT/Sinus • Wound • GI related infections. Find out how to CAPTURE OUTSIDE LAB REVENUE and improve patient experience and outcomes. (8) tests a day generates you over $30K in bottom-line revenue & advances patient care with a 1-hour test result that includes antibiotic resistance read-out.
https://optimalhealthadvocates.com/
UROLOGY • OB/GYN • INTERNAL MEDICINE • PRIMARY CARE • URGENT CARE • PEDIATRICS • ENT/ALLERGY • WOUND CARE
PROVEN PROGRAM:
✅ Over 100 Established Locations across the United States -- each generating at least $30K/month in bottom-line revenue.
✅ ELIMINATE delayed or ineffective antibiotic treatment & costly last-minute surgery cancellations (1-hour turn-around for results with antibiotic resistance read-out);
✅ Keep your providers compliant with CDC Antibiotic Stewardship Program (that is soon to be mandated in the clinical setting) with our program's monthly reports that will increase your facility health score by showing you are reducing the use of unnecessary antibiotics with PCR testing that is 96% more accurate than a traditional culture.
We handle ALL of the upfront capital costs, billing, staffing, and CLIA licensure/compliance at NO UPFRONT COST TO THE PRACTICE -- All that’s required is a 6-foot workspace to run the tests.
To LEARN MORE and SEE IF YOUR PRACTICE QUALIFIES, Book a 10-min Discovery Call with Jen here:
https://go.oncehub.com/Advanced_In-Office_PCR_Lab_Discovery-Call
Optimal Health Advocates as an Ancillary Medical Practice Revenue Generation company helping medical practices capture significant revenue increases while improving patient lives and outcomes.
--------------
Jennifer Anderson is a 20-year Practice Manager, entrepreneur, and digital marketing expert who intimately understands the challenges of the business of medicine and is passionate about helping Medical Sales Companies and Medical Practices successfully implement systems and services that enhance and save patient lives and increase practice revenue. Just In Time Clinical Trial Monitoring Final
Just-in-Time monitoring is an event-driven monitoring paradigm where sites are monitored after key events like the enrollment of the first subject and every third subject, rather than on a fixed schedule. It allows monitors to review enrollment and data remotely using electronic data capture systems. This helps identify issues early, strengthen relationships with sites by being less disruptive, focus on compliance, and avoid CRA burnout from excessive travel. Studies using Just-in-Time monitoring see benefits like reduced costs from more efficient use of monitoring resources and capacity aligned with enrollment.
Dr. negi quality assurance
This document discusses quality improvement of laboratory services in Chhattisgarh, India. It begins by outlining common diseases in the region like tuberculosis, HIV, leprosy, and waterborne illnesses. The importance of laboratory diagnosis for proper disease management is emphasized. Major bottlenecks in laboratories include insufficient staffing and resources as well as a lack of coordination between doctors and laboratories. Steps to improve quality include implementing standard operating procedures, conducting internal and external quality control, ensuring proper documentation, and training laboratory personnel. The overall goals are to support high-quality healthcare through accurate and reliable test results.
Recommended
Developing a Test for COVID-19 at Michigan Medicine
Developing a Test for COVID-19 at Michigan MedicineUniversity of Michigan Department of Emergency Medicine
This document summarizes the development of COVID-19 testing at Michigan Medicine. It discusses the process of obtaining FDA approval or emergency use authorization for tests, challenges in developing and validating new tests, and lessons learned from expanding testing capacity. Initial efforts focused on verifying and validating tests from CDC protocols and commercial vendors. Over time, testing was expanded to more patients using high-throughput and rapid turnaround time assays. Challenges included shortages of collection kits and regulatory barriers, while lessons highlighted the need for better integration between clinical labs, public health, and industry in response to emerging diseases.Driving Point of Care Technology Development: Integrated Approach to Consensu...
The WALEX process combines facilitated discussion and discrete choice experiments to define the attributes of a realistic point-of-care test for Chlamydia trachomatis. Key findings include:
1) Participants were willing to accept longer test times and slightly higher instrument costs to preserve attributes like lower test cost, vaginal sample type, and processing multiple samples per batch.
2) Analysis of survey data identified where participants were willing to compromise on attributes and where they were unwilling.
3) The methodology provides a way to understand user needs and tradeoffs to help bridge the gap between need and realization of new diagnostic technologies.
Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisse...
Laboratory Recommendations for the Detection of Chlamydia trachomatis, Neisse...National Chlamydia Coalition
Presented by John R. Papp, Senior Service Fellow, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, at the 2010 National Chlamydia Coalition meetingM tyagi resume 2019
This document provides a summary of the qualifications and experience of Manoj Tyagi, Ph.D. He has over 15 years of experience in quality management, regulatory compliance, and laboratory accreditation. Currently he serves as the Chief Scientific Officer and Laboratory Director of Captiva Lab LLC, where he oversees CLIA and accreditation compliance. He has extensive expertise in clinical chemistry, toxicology, and workplace drug testing.
Diagnostic Testing Conference 2020
The Diagnostic & Testing virtual conference held on the 11th June 2020 was an inspiring event examining the role of both molecular and rapid diagnostics in tackling disease, infection and reducing the impact of COVID-19 within our communities and hospitals. The virtual conference explored how health professionals, academics and industry are driving diagnostic and testing usage within laboratories, pharmacies and community practice.
The conference built upon the UK Diagnostics Summit held annually in London discussed how diagnostics and testing are tackling COVID-19, the technology in development, accuracy of COVID-19 tests as well as exploring current testing methods for cancer, diabetes, sepsis, urinary tract infections and HAI’S.
Advanced In-Office 1-hour PCR LAB - Ancillary Revenue Program
Advanced In-Office 1-hour PCR LAB - Ancillary Revenue ProgramOptimal Health Advocates-Ancillary Revenue Generation Specialists
Ancillary Revenue Program - Are you still sending out these tests to an outside lab? UTI/STI • Vaginitis • Respiratory • ENT/Sinus • Wound • GI related infections. Find out how to CAPTURE OUTSIDE LAB REVENUE and improve patient experience and outcomes. (8) tests a day generates you over $30K in bottom-line revenue & advances patient care with a 1-hour test result that includes antibiotic resistance read-out.
https://optimalhealthadvocates.com/
UROLOGY • OB/GYN • INTERNAL MEDICINE • PRIMARY CARE • URGENT CARE • PEDIATRICS • ENT/ALLERGY • WOUND CARE
PROVEN PROGRAM:
✅ Over 100 Established Locations across the United States -- each generating at least $30K/month in bottom-line revenue.
✅ ELIMINATE delayed or ineffective antibiotic treatment & costly last-minute surgery cancellations (1-hour turn-around for results with antibiotic resistance read-out);
✅ Keep your providers compliant with CDC Antibiotic Stewardship Program (that is soon to be mandated in the clinical setting) with our program's monthly reports that will increase your facility health score by showing you are reducing the use of unnecessary antibiotics with PCR testing that is 96% more accurate than a traditional culture.
We handle ALL of the upfront capital costs, billing, staffing, and CLIA licensure/compliance at NO UPFRONT COST TO THE PRACTICE -- All that’s required is a 6-foot workspace to run the tests.
To LEARN MORE and SEE IF YOUR PRACTICE QUALIFIES, Book a 10-min Discovery Call with Jen here:
https://go.oncehub.com/Advanced_In-Office_PCR_Lab_Discovery-Call
Optimal Health Advocates as an Ancillary Medical Practice Revenue Generation company helping medical practices capture significant revenue increases while improving patient lives and outcomes.
--------------
Jennifer Anderson is a 20-year Practice Manager, entrepreneur, and digital marketing expert who intimately understands the challenges of the business of medicine and is passionate about helping Medical Sales Companies and Medical Practices successfully implement systems and services that enhance and save patient lives and increase practice revenue. Just In Time Clinical Trial Monitoring Final
Just-in-Time monitoring is an event-driven monitoring paradigm where sites are monitored after key events like the enrollment of the first subject and every third subject, rather than on a fixed schedule. It allows monitors to review enrollment and data remotely using electronic data capture systems. This helps identify issues early, strengthen relationships with sites by being less disruptive, focus on compliance, and avoid CRA burnout from excessive travel. Studies using Just-in-Time monitoring see benefits like reduced costs from more efficient use of monitoring resources and capacity aligned with enrollment.
Dr. negi quality assurance
This document discusses quality improvement of laboratory services in Chhattisgarh, India. It begins by outlining common diseases in the region like tuberculosis, HIV, leprosy, and waterborne illnesses. The importance of laboratory diagnosis for proper disease management is emphasized. Major bottlenecks in laboratories include insufficient staffing and resources as well as a lack of coordination between doctors and laboratories. Steps to improve quality include implementing standard operating procedures, conducting internal and external quality control, ensuring proper documentation, and training laboratory personnel. The overall goals are to support high-quality healthcare through accurate and reliable test results.
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
Join experts from Medpace’s regulatory and operational teams in this webinar as they provide insights and considerations on how to accelerate product development for COVID-19 during different stages
Cambridge oncometrix 230317
company presentation. Development of the prostate cancer diagnostic test and in-vitro diagnostic device for the point-of-care diagnosis of prostate cancer
QMS at the Site
This document discusses the paradigm shift towards quality management systems and risk-based monitoring at clinical research sites. It emphasizes that sites must adapt to industry standards like risk-based principles in order to ensure data quality and validity. A successful site will implement a quality management system through preventative measures like risk assessment and auditing. This helps identify issues, ensure compliance, and mitigate risks to subjects, data and the site's sustainability.
FROM KAMPALA TO CAPE TOWN
1) This document discusses the challenges and opportunities for conducting HIV vaccine clinical trials across Africa. It outlines several networks that conduct such trials, including ongoing studies in South Africa, Tanzania, Kenya, and other countries.
2) Regulatory approval for clinical trials can often be a lengthy process, taking over 100 days on average for some studies. Harmonization of regulatory systems and increasing local expertise could help address challenges.
3) International collaboration and engagement with local stakeholders is important for ensuring trials are conducted effectively and ethically. Capacity building aims to strike the right balance between scientific goals and respecting local contexts.
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
n this free webinar, Medpace partners with Michelle Eagle of ATOM International, a provider of CE training for clinical trials across the world, to discuss approaches and steps that can be taken to ensure quality and integrity.
Quality Control for Point of Care Testing - White Paper
Point of care testing (POCT) refers to testing that is performed near or at the site of a patient with the result leading to a possible change in the care of the patient. Over the past few years, the popularity and demand of POCT has been growing rapidly. This should come as no surprise as there are many advantages to POCT, for example, the added convenience of being able to obtain a rapid result at the patient’s bedside, thus allowing immediate action, saving time and improving the potential outcome for the patient.
Roadmap Molecular Diagnostics
This document outlines a roadmap for developing molecular diagnostics in the Netherlands. It discusses the need to integrate biomarker discovery with diagnostic test development and clinical application. The goal is to define a framework that facilitates moving candidate biomarkers through validation and regulatory approval to reimbursed clinical use. This will help address unmet medical needs through improved personalized healthcare.
Accelerating the translation of medical research - 27 June
Slides from the event focusing on translational research in Liverpool and North of England and why companies are establishing and growing operations in the region.
Conduct of clinical Trials during covid 19 a CTTI webinar
This week, stakeholders from across the clinicaltrials ecosystem submitted experiences and insights related to the FDA’s new guidance on the #conduct of clinical trials of medical products during the current hashtag#COVID-19 pandemic. We shared best practices and experiences in a webinar and our slides are now available in advance of posting the webinar.
Improving the Quality and Value of the Laboratory Self-Inspection - Best of A...
How to improve Self - inspection, a primary CAP accreditation requirement, in order to achieve the best outcome
Poct in your pediatric OPD practice
The document discusses point-of-care testing (POCT) in outpatient departments. It defines POCT as medical diagnostic testing performed close to patients and outside clinical laboratories. Key benefits of POCT include faster results and feedback to patients, enabling timely treatment. Specific POCT tests mentioned include complete blood count, blood gases, glucose, CRP, lipid profiles, and urine tests. Challenges of POCT include ensuring quality and appropriate use. The document argues POCT can help reduce unnecessary antibiotic prescription by providing rapid white blood cell counts for pediatric patients.
Microbioloy and clinical interaction ...
Dr. T.V. Rao discusses how microbiologists and clinicians can improve diagnostic microbiology through better interaction and understanding each other's roles. Many microbiologists work in isolation without understanding clinical implications. Clinicians also do not fully utilize laboratory results. This has led to increasing antibiotic resistance and worse patient outcomes. Dr. Rao proposes several responsibilities for microbiologists, including providing guidelines for proper specimen collection, maintaining an effective computer system for testing and reporting, and periodically publishing antibiotic susceptibility patterns. He also stresses the importance of quality control and open communication between microbiologists and clinicians.
Where are We in the Search for an HIV Vaccine?
This document summarizes the current state of HIV/AIDS and efforts towards developing an HIV vaccine. It notes that as of 2013, there are over 34 million people living with HIV globally, with 2.7 million new infections and 2 million AIDS-related deaths that year. Developing an effective HIV vaccine or other prevention method faces major challenges, as the process from discovery to regulatory approval for other vaccines has typically taken decades. The development of an HIV vaccine involves basic research, prototype design, pre-clinical testing, and clinical trials - which is a long, complex process requiring collaboration between different areas of expertise. While there has been some promising research, an HIV vaccine is still likely many years away due to the difficulties of the process.
Good Laboratory Practices Mubashir Maqbool
GLP (Good Laboratory Practice) is a quality system for managing non-clinical laboratory studies to ensure reliability and integrity of test data. It outlines requirements for facility organization, personnel responsibilities, quality assurance programs, standard operating procedures, and retention of records and reports. GLP aims to ensure studies are well-designed, conducted and documented according to all principles to allow for traceability and reproducibility of results.
Resume2018
This candidate has over 15 years of experience as a certified histotechnologist, including over 5 years of supervisory experience. She has proficiency in immunohistochemistry, fluorescent in situ hybridization, antibody validation, Mohs histology, and digital pathology. She is qualified in immunohistochemistry and eligible for licensure in Florida. Her experience includes positions as a lead histotechnologist, histotechnologist III, histotechnologist II, and histology supervisor at various hospitals and medical laboratories.
Resume.11.21.2
Lindsay LaMere has over 10 years of experience in clinical laboratory quality assurance and management. She currently works as a Quality Assurance Specialist at Sutter Health, where she coordinates quality activities for over 200 tests and 2 million samples per year. Previously, she held positions as a Laboratory Manager and Clinical Laboratory Scientist. She has extensive experience with regulatory compliance, process improvement, auditing, and training.
Helen Cantwell - State Laboratory
This document discusses challenges in method validation from a regulatory laboratory perspective. It begins by defining validation and why it is important. Developing a validation procedure requires following accreditation standards and legislation. Harmonizing the validation approach has advantages like allowing results comparison. Key challenges include a lack of certified analytical standards, validating for multiple matrices, calculating measurement uncertainty, finding proficiency tests, ongoing verification, and determining what constitutes revalidation. The document promotes Eurachem resources on method validation and an upcoming Irish workshop on the topic.
Multiplex Arrays for POC infection detention
Randox is developing multiplex biochip arrays for point-of-care infection detection. Their technology allows up to 100 tests to be performed simultaneously on a single sample. They have developed arrays for sexually transmitted infections, respiratory infections, urinary tract infections, and sepsis. The sepsis array detects 47 bacterial and fungal targets and 3 antibiotic resistance genes directly from blood within 4 hours, which could transform sepsis care. Randox is also continually developing new molecular multiplex assays and working with clinical partners to define diagnostic needs.
Centralized vs. Onsite Monitoring
Sandra Maddock, RN, BSN, CCRA and President of IMARC Research, Inc. presents on Applying FDA’s Risk-Based Approach in an audio conference on September 11, 2012.
In-Vitro-Diagnostics- Agenda
This document provides information about the "In Vitro Diagnostics: Oncology & Infectious Diseases Conference" being held on November 9-10, 2016 in London. The conference will bring together professionals from hospitals, reference laboratories, and the IVD industry to discuss potential growth in oncology and infectious disease diagnostics and related challenges. Over the two days, the conference will feature keynote presentations, panel discussions, and case studies on topics like emerging regulations, novel cancer markers, rapid testing for infectious diseases, and quality control of point-of-care testing.
Pyrogen and pyrogenicity
This document summarizes information about pyrogens and pyrogenicity. It defines pyrogens as agents that cause an increase in body temperature when injected. The most common pyrogens in pharmaceuticals are bacterial endotoxins from gram-negative bacteria. There are two classes of pyrogens - endogenous pyrogens produced within the body and exogenous pyrogens from external sources. Common sources of pyrogens in pharmaceutical products include water, materials, and equipment. The rabbit pyrogen test involves injecting a substance into rabbits and measuring temperature changes, while the LAL test detects endotoxins using lysate from horseshoe crab blood.
Sop ftir
This document outlines the standard operating procedure and calibration for an FTIR spectrometer. It describes the responsibilities and procedures for general cleaning, operation, sample preparation for solids, liquids, and oil dispersions, scanning, and calibration. Calibration is performed every 3 months using a polystyrene film to check wave number accuracy and resolution performance. Any issues identified during calibration must be reported.
More Related Content
What's hot
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
Join experts from Medpace’s regulatory and operational teams in this webinar as they provide insights and considerations on how to accelerate product development for COVID-19 during different stages
Cambridge oncometrix 230317
company presentation. Development of the prostate cancer diagnostic test and in-vitro diagnostic device for the point-of-care diagnosis of prostate cancer
QMS at the Site
This document discusses the paradigm shift towards quality management systems and risk-based monitoring at clinical research sites. It emphasizes that sites must adapt to industry standards like risk-based principles in order to ensure data quality and validity. A successful site will implement a quality management system through preventative measures like risk assessment and auditing. This helps identify issues, ensure compliance, and mitigate risks to subjects, data and the site's sustainability.
FROM KAMPALA TO CAPE TOWN
1) This document discusses the challenges and opportunities for conducting HIV vaccine clinical trials across Africa. It outlines several networks that conduct such trials, including ongoing studies in South Africa, Tanzania, Kenya, and other countries.
2) Regulatory approval for clinical trials can often be a lengthy process, taking over 100 days on average for some studies. Harmonization of regulatory systems and increasing local expertise could help address challenges.
3) International collaboration and engagement with local stakeholders is important for ensuring trials are conducted effectively and ethically. Capacity building aims to strike the right balance between scientific goals and respecting local contexts.
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
n this free webinar, Medpace partners with Michelle Eagle of ATOM International, a provider of CE training for clinical trials across the world, to discuss approaches and steps that can be taken to ensure quality and integrity.
Quality Control for Point of Care Testing - White Paper
Point of care testing (POCT) refers to testing that is performed near or at the site of a patient with the result leading to a possible change in the care of the patient. Over the past few years, the popularity and demand of POCT has been growing rapidly. This should come as no surprise as there are many advantages to POCT, for example, the added convenience of being able to obtain a rapid result at the patient’s bedside, thus allowing immediate action, saving time and improving the potential outcome for the patient.
Roadmap Molecular Diagnostics
This document outlines a roadmap for developing molecular diagnostics in the Netherlands. It discusses the need to integrate biomarker discovery with diagnostic test development and clinical application. The goal is to define a framework that facilitates moving candidate biomarkers through validation and regulatory approval to reimbursed clinical use. This will help address unmet medical needs through improved personalized healthcare.
Accelerating the translation of medical research - 27 June
Slides from the event focusing on translational research in Liverpool and North of England and why companies are establishing and growing operations in the region.
Conduct of clinical Trials during covid 19 a CTTI webinar
This week, stakeholders from across the clinicaltrials ecosystem submitted experiences and insights related to the FDA’s new guidance on the #conduct of clinical trials of medical products during the current hashtag#COVID-19 pandemic. We shared best practices and experiences in a webinar and our slides are now available in advance of posting the webinar.
Improving the Quality and Value of the Laboratory Self-Inspection - Best of A...
How to improve Self - inspection, a primary CAP accreditation requirement, in order to achieve the best outcome
Poct in your pediatric OPD practice
The document discusses point-of-care testing (POCT) in outpatient departments. It defines POCT as medical diagnostic testing performed close to patients and outside clinical laboratories. Key benefits of POCT include faster results and feedback to patients, enabling timely treatment. Specific POCT tests mentioned include complete blood count, blood gases, glucose, CRP, lipid profiles, and urine tests. Challenges of POCT include ensuring quality and appropriate use. The document argues POCT can help reduce unnecessary antibiotic prescription by providing rapid white blood cell counts for pediatric patients.
Microbioloy and clinical interaction ...
Dr. T.V. Rao discusses how microbiologists and clinicians can improve diagnostic microbiology through better interaction and understanding each other's roles. Many microbiologists work in isolation without understanding clinical implications. Clinicians also do not fully utilize laboratory results. This has led to increasing antibiotic resistance and worse patient outcomes. Dr. Rao proposes several responsibilities for microbiologists, including providing guidelines for proper specimen collection, maintaining an effective computer system for testing and reporting, and periodically publishing antibiotic susceptibility patterns. He also stresses the importance of quality control and open communication between microbiologists and clinicians.
Where are We in the Search for an HIV Vaccine?
This document summarizes the current state of HIV/AIDS and efforts towards developing an HIV vaccine. It notes that as of 2013, there are over 34 million people living with HIV globally, with 2.7 million new infections and 2 million AIDS-related deaths that year. Developing an effective HIV vaccine or other prevention method faces major challenges, as the process from discovery to regulatory approval for other vaccines has typically taken decades. The development of an HIV vaccine involves basic research, prototype design, pre-clinical testing, and clinical trials - which is a long, complex process requiring collaboration between different areas of expertise. While there has been some promising research, an HIV vaccine is still likely many years away due to the difficulties of the process.
Good Laboratory Practices Mubashir Maqbool
GLP (Good Laboratory Practice) is a quality system for managing non-clinical laboratory studies to ensure reliability and integrity of test data. It outlines requirements for facility organization, personnel responsibilities, quality assurance programs, standard operating procedures, and retention of records and reports. GLP aims to ensure studies are well-designed, conducted and documented according to all principles to allow for traceability and reproducibility of results.
Resume2018
This candidate has over 15 years of experience as a certified histotechnologist, including over 5 years of supervisory experience. She has proficiency in immunohistochemistry, fluorescent in situ hybridization, antibody validation, Mohs histology, and digital pathology. She is qualified in immunohistochemistry and eligible for licensure in Florida. Her experience includes positions as a lead histotechnologist, histotechnologist III, histotechnologist II, and histology supervisor at various hospitals and medical laboratories.
Resume.11.21.2
Lindsay LaMere has over 10 years of experience in clinical laboratory quality assurance and management. She currently works as a Quality Assurance Specialist at Sutter Health, where she coordinates quality activities for over 200 tests and 2 million samples per year. Previously, she held positions as a Laboratory Manager and Clinical Laboratory Scientist. She has extensive experience with regulatory compliance, process improvement, auditing, and training.
Helen Cantwell - State Laboratory
This document discusses challenges in method validation from a regulatory laboratory perspective. It begins by defining validation and why it is important. Developing a validation procedure requires following accreditation standards and legislation. Harmonizing the validation approach has advantages like allowing results comparison. Key challenges include a lack of certified analytical standards, validating for multiple matrices, calculating measurement uncertainty, finding proficiency tests, ongoing verification, and determining what constitutes revalidation. The document promotes Eurachem resources on method validation and an upcoming Irish workshop on the topic.
Multiplex Arrays for POC infection detention
Randox is developing multiplex biochip arrays for point-of-care infection detection. Their technology allows up to 100 tests to be performed simultaneously on a single sample. They have developed arrays for sexually transmitted infections, respiratory infections, urinary tract infections, and sepsis. The sepsis array detects 47 bacterial and fungal targets and 3 antibiotic resistance genes directly from blood within 4 hours, which could transform sepsis care. Randox is also continually developing new molecular multiplex assays and working with clinical partners to define diagnostic needs.
Centralized vs. Onsite Monitoring
Sandra Maddock, RN, BSN, CCRA and President of IMARC Research, Inc. presents on Applying FDA’s Risk-Based Approach in an audio conference on September 11, 2012.
In-Vitro-Diagnostics- Agenda
This document provides information about the "In Vitro Diagnostics: Oncology & Infectious Diseases Conference" being held on November 9-10, 2016 in London. The conference will bring together professionals from hospitals, reference laboratories, and the IVD industry to discuss potential growth in oncology and infectious disease diagnostics and related challenges. Over the two days, the conference will feature keynote presentations, panel discussions, and case studies on topics like emerging regulations, novel cancer markers, rapid testing for infectious diseases, and quality control of point-of-care testing.
What's hot (20)
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
COVID-19 Product Development and Clinical Trials: Considerations from Europea...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Part 3: Rare Disease Clinical Development – Strategies for Ensuring Endpoint ...
Quality Control for Point of Care Testing - White Paper
Quality Control for Point of Care Testing - White Paper
Accelerating the translation of medical research - 27 June
Accelerating the translation of medical research - 27 June
Conduct of clinical Trials during covid 19 a CTTI webinar
Conduct of clinical Trials during covid 19 a CTTI webinar
Improving the Quality and Value of the Laboratory Self-Inspection - Best of A...
Improving the Quality and Value of the Laboratory Self-Inspection - Best of A...
Viewers also liked
Pyrogen and pyrogenicity
This document summarizes information about pyrogens and pyrogenicity. It defines pyrogens as agents that cause an increase in body temperature when injected. The most common pyrogens in pharmaceuticals are bacterial endotoxins from gram-negative bacteria. There are two classes of pyrogens - endogenous pyrogens produced within the body and exogenous pyrogens from external sources. Common sources of pyrogens in pharmaceutical products include water, materials, and equipment. The rabbit pyrogen test involves injecting a substance into rabbits and measuring temperature changes, while the LAL test detects endotoxins using lysate from horseshoe crab blood.
Sop ftir
This document outlines the standard operating procedure and calibration for an FTIR spectrometer. It describes the responsibilities and procedures for general cleaning, operation, sample preparation for solids, liquids, and oil dispersions, scanning, and calibration. Calibration is performed every 3 months using a polystyrene film to check wave number accuracy and resolution performance. Any issues identified during calibration must be reported.
Pyrogen 112070804004
This document defines pyrogens as fever-producing substances produced by microorganisms. It classifies pyrogens into two categories: exogenous pyrogens which come from outside the body and endogenous pyrogens which are produced within the body in response to exogenous pyrogens. The most potent pyrogens are endotoxins from gram-negative bacterial cell walls. Endotoxins elicit inflammatory responses and activate the complement system. Their biological activity is associated with the lipopolysaccharide component, specifically the toxic lipid A portion. Endotoxins can cause harmful physiological effects but also stimulate immune defenses.
Sem n tem
Electron microscopes use a beam of electrons to examine objects at a very fine scale. There are two main types - transmission electron microscopes (TEM) and scanning electron microscopes (SEM). TEMs allow study of inner structures by transmitting electrons through thin samples, while SEMs visualize surface topography by scanning sample surfaces. Both have advanced biological and materials applications due to their high resolving power and ability to produce detailed images at the nanoscale level. Recent developments include aberration correction to further improve resolution.
Calibration and validation of analytical instruments
This document discusses the calibration and validation of various analytical instruments used in pharmaceutical analysis. It provides details on calibrating UV-Vis spectrophotometers, IR spectrophotometers, spectrofluorimeters, HPLC, and GC. Calibration ensures instrument readings are accurate against standards, while validation confirms the instrument is correctly installed and operating as intended. The document outlines tests and acceptance criteria for evaluating characteristics like wavelength accuracy, resolution, noise, baseline flatness, sensitivity, flow rate, and linearity during calibration and validation of different analytical instruments.
Gas chromatography
This document provides an introduction to gas chromatography including its components, advantages, and applications. It discusses the basic process of separating components using an inert gaseous mobile phase and immobilized liquid or solid stationary phase. Key components are described including the carrier gas, sample injection port, columns, and common detectors like FID and TCD. Applications include qualitative and quantitative analysis of compounds like oils, fatty acids, foods, drugs, and pollutants.
Industry Overview: Big Data Fuels Intelligence-Driven Security
This industry overview describes how Big Data will be a driver for change across the security industry, reshaping security approaches, solutions, and spending. It presents six guidelines to help organizations plan for the Big Data-driven transformation of their security toolsets and operations as part of an intelligence-driven security program.
Tema 15 la representación de los datos
Este documento describe diferentes métodos para representar datos, incluyendo tablas de frecuencias, gráficas de barras y circulares. Explica cómo construir estas representaciones visuales a partir de datos recopilados, y cómo calcular la media y moda. También incluye enlaces a juegos y videos relacionados con la representación de datos.
PBA Blog 1.8.13
The document summarizes key statistics from HubSpot's 2012 State of Inbound Marketing report. Some of the main findings are that 78% of internet users conduct online product research, inbound leads cost 61% less than outbound leads, and 57% of companies have acquired customers from their blog. It also notes that 62% of companies report social media becoming more important for leads, while 51% report direct mail becoming less important. The document promotes attending an upcoming presentation by the author to learn how to develop an inbound marketing process to increase revenue.
Fed's monetary policy quesitons
This document contains questions about economic concepts such as inflation, recessions, and monetary policy. It also provides data on the declines in GDP, unemployment, and world trade during the Great Depression and Great Recession. Additionally, it poses questions about what monetary policy the Federal Reserve should pursue in different time periods between the 1950s and 2010s based on the economic conditions of each respective era. The document instructs students to write a letter to the Federal Reserve Chairman outlining whether they support an expansionary or contractionary policy given 2013 unemployment and inflation rates. Finally, it prompts drafting a letter to a Congressman regarding two fiscal policy changes agreed with and their potential effects.
What must a leader bear in mind when attempting to change workplace culture
Leaders must lead by example to inspire cultural change. Several contributors agreed that a leader must live the culture themselves and demonstrate the desired behaviors. Change takes time and persistence from the leader. While leaders can influence change, it is ultimately the employees who create change when a large portion want reform. A leader's actions must show enthusiasm for the cultural changes for employees to buy in.
Cybercrime and the Healthcare Industry
This white paper discusses the various cyber threats targeting healthcare organizations and the challenges security professionals face in securing access to protected health information.
Toilet cleaner
An unemployed man applies for a janitor position at Microsoft but is denied the job when he says he does not have an email address. Struggling with only $10, he decides to buy and sell strawberries door-to-door, doubling his money each time. Over five years, he builds a successful food delivery business through hard work. He later realizes that if he had an email at the start, he may have just ended up a toilet cleaner at Microsoft instead of a millionaire businessman.
Presentación
This document provides biographical information about Charles Perrault and summaries of some of his famous fairy tales including Puss in Boots and Riquet with the Tuft. It discusses his life and work writing fairy tales in 17th century France. Some of the key elements that define the tales as fairy tales are identified such as magic, enchantments, royalty/poverty, good vs evil characters, and happy beginnings and endings. The tales share common patterns and themes that have become universally recognizable aspects of the fairy tale genre.
Copyright presentation
The creator of original work has exclusive copyright over that work. Anyone wishing to use the copyrighted work must obtain permission from the copyright owner. This permission can be denied. Copyright lasts for a limited time, during which the owner receives financial benefits and credit for the work. Items with copyright display the © symbol. Unauthorized use of copyrighted material without permission is considered theft under legal copyright laws.
Monopoly types
This document provides an overview of monopolies and monopoly markets. It begins with a bellringer asking questions about monopolies. It then defines a monopoly as a market with a single dominant seller and notes that monopolies have high barriers to entry. It discusses types of monopolies including geographic, government-granted, and technological monopolies. It provides examples of different types of monopolies. The document discusses price discrimination in monopoly markets and consumer and producer surplus. It closes with questions about why economists worry about monopolies and why technological monopolies are allowed to exist.
Creative examples of origami logo design for inspiration
The document showcases 40+ examples of origami-inspired logo designs. It discusses how origami, the art of paper folding, can provide hundreds of ideas for logo creation. The logos displayed are simple yet creative representations of origami shapes and objects folded from paper. They provide inspiration for those hoping to design their own origami-themed logos.
Viewers also liked (20)
Calibration and validation of analytical instruments
Calibration and validation of analytical instruments
Industry Overview: Big Data Fuels Intelligence-Driven Security
Industry Overview: Big Data Fuels Intelligence-Driven Security
What must a leader bear in mind when attempting to change workplace culture
What must a leader bear in mind when attempting to change workplace culture
Creative examples of origami logo design for inspiration
Creative examples of origami logo design for inspiration
Similar to Choosing best laboratory practice
691632.ppt
Point of care testing can provide clinical and economic benefits over centralized laboratory testing by decreasing turnaround time through elimination of transport and processing delays. This allows for more timely medical decisions and reduces unnecessary additional testing and treatment. Currently available microbiology point of care tests include those for group A strep, H. pylori, HIV, and various provider performed microscopic exams. Advantages include rapid results and controls, while disadvantages include potential for false results and need for training on test procedures.
Quality Assurance Qual Indicators.ppt
This document discusses quality assurance in mycobacteriology laboratories. It describes the three main components of a quality assurance system as quality control, external quality assessment, and quality improvement. Quality control procedures should address pre-analytical, analytical, and post-analytical phases of testing. Monitoring performance indicators such as contamination rates, turnaround times, and proficiency testing scores helps to evaluate laboratory performance and identify areas for improvement.
Invest to End TB. Save Lives
The document summarizes recent updates in tuberculosis (TB) diagnostics and treatment. It discusses improvements and gaps in diagnosing TB infection versus active disease. New World Health Organization recommendations for TB diagnostics are outlined. Challenges in aligning current diagnostics with new multidrug-resistant TB treatment options are described. The future of TB diagnostics includes biomarkers and moving away from reliance on sputum samples for diagnosis. New tests are needed to address diagnostic gaps and better monitor treatment response.
Quality assurance
This document discusses quality improvement of laboratory services in Chhattisgarh, India. It outlines several diseases prevalent in the state and emphasizes the importance of laboratory diagnosis in disease management. It identifies major issues with laboratories including insufficient staffing and resources. The document proposes several solutions such as establishing standard operating procedures, implementing internal and external quality control programs, improving documentation, and calibration of equipment. The goal is to support high-quality healthcare through reliable laboratory testing.
Group_3_M - Cancer Research Laboratory.pptx
This presentation discusses good laboratory practices (GLP) in cancer research laboratories. It outlines the key working procedures in cancer research, including formulating questions, gathering tools, conducting experiments, and analyzing and sharing findings. The importance of adhering to GLP is emphasized to ensure reliable outcomes through maintaining high standards. Certifications like CLIA, AAALAC, CAP, IACUC, and IBC are also covered that are relevant for cancer research. Quality assurance and quality control are important for achieving accurate results and preventing errors. In summary, following proper procedures, regulations, and implementing GLP and quality measures helps produce trustworthy data to advance cancer research.
Maintaining quality in molecular Diagnostics final layout
The document discusses key components of establishing and maintaining a quality system for molecular genetic testing laboratories. It outlines the need for quality assurance in molecular diagnostics given the increasing applications and complexity. The major components covered include planning, validation of test performance, pre-examination, examination and post-examination processes, and implementing quality system essentials with a focus on information management and assessment. The goal is to provide guidance for laboratories to deliver accurate and reliable genetic testing services.
Assay Standardisation - how this leads to improved patient results
Clare Morris from NIBSC discusses the importance of assay standardization for improving patient results. Standardization leads to more accurate, robust and reproducible diagnostic assays by providing a common unit of measurement for comparison. This allows results from different laboratories and assays to be comparable. NIBSC establishes biological reference standards and reference materials to facilitate standardization. Examples are given showing how standardization has improved comparability for assays measuring PSA, HCV RNA, HIV RNA, and other markers. Challenges in standardizing assays across different sample matrices are also discussed.
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGYYasser Sami Abdel Dayem Amer
evidence-based clinical practical guidelines adaptation for department of obstetrics and gynecology, king saud university hospitalsMODERN REQUIREMENTS OF AN ASSISTED REPRODUCTIVE CENTER OF EXCELLENCE
Talk delivered at "ART Experts & Merck - Shaping the Future of Fertility”, Rio de Janeiro, BRAZIL, April 27th, 2019.
Qps Presentation
QPS is a contract research organization that provides discovery, preclinical, and clinical development services including bioanalysis, DMPK, biomarkers, and early phase clinical research. It has facilities in Newark, DE, Taipei, Taiwan, and Springfield, MO that are GLP compliant. QPS supports clients through all phases of drug development with specialized services including bioanalysis, PK/PD analysis, ADME studies, and clinical research.
Colorectal screening evidence & colonoscopy screening guidelines
Health Evidence hosted a 90 minute webinar examining colorectal cancer screening: benefits and harms, effective screening methods, and screening guidelines.Click here for access to the audio recording for this webinar: https://www.youtube.com/watch?v=JqOV-KHCBq8
Donna Fitzpatrick-Lewis, MSW, Senior Research Coordinator at the McMaster Evidence Review and Synthesis Centre and Dr. Maria Bacchus, Associate Professor of Medicine, Faculty of Medicine University of Calgary, and member of the Canadian Task Force on Preventive Health Care led the session. Donna presented the findings of the Synthesis Centre’s latest review and Dr. Bacchus presented findings from the Task Force’s latest guidelines:
Fitzpatrick-Lewis, D., Usman, A., Warren, R., Kenny, M., Rice, M., Bayer, A., Ciliska, D., Sherifali, D., Raina, P. Screening for colorectal cancer. Ottawa: Canadian Task Force on Preventive Health Care; 2015. Available: http://canadiantaskforce.ca/files/crc-screeningfinal2.pdf
Bacchus, C. M., Dunfield, L., Gorber, S. C., Holmes, N. M., Birtwhistle, R., Dickinson, J. A., Lewin, G., Singh, H., Klarenbach, S., Mai, V., Tonelli, M. (2016). Recommendations on screening for colorectal cancer in primary care. Canadian Medical Association Journal, cmaj-151125.
Among men and women, colorectal cancer is the second and third most common cause of cancer related death, respectively. Colorectal cancer screening guidelines, developed by the Canadian Task Force on Preventive Health Care, are based on a systematic review synthesizing evidence on the benefits and harms of screening, and the characteristics of effective screening tests. The guidelines, developed from the review, outline screening recommendations for adults aged 50 and older who are asymptomatic and not at high risk for colorectal cancer. This webinar provided a high level overview of the systematic review that informed these recommendations, followed by an overview of the recent Canadian screening guidelines.
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Learn about existing and emerging methods to accelerate biosafety testing of biologic therapies.
Speed to market for biologic therapeutics is ever more critical. However, the critical safety tests for these molecules, for example screening for adventitious agents such as viral contaminants, can be time consuming as well as challenging and laborious. Join us for this webinar as we explore how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity. Existing technologies as well as emerging trends will be discussed, along with the implications these may have on the regulatory landscape.
In this webinar you will learn:
● Which existing and emerging technologies are having now, and will have in the future, an impact on biosaftey testing.
● The benefits as well as risks of employing rapid methods for biosafety screening.
● How the regulatory agencies are reacting to rapid testing methods as alternatives to existing methods.
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Learn about existing and emerging methods to accelerate biosafety testing of biologic therapies.
Speed to market for biologic therapeutics is ever more critical. However, the critical safety tests for these molecules, for example screening for adventitious agents such as viral contaminants, can be time consuming as well as challenging and laborious. Join us for this webinar as we explore how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity. Existing technologies as well as emerging trends will be discussed, along with the implications these may have on the regulatory landscape.
In this webinar you will learn:
● Which existing and emerging technologies are having now, and will have in the future, an impact on biosaftey testing.
● The benefits as well as risks of employing rapid methods for biosafety screening.
● How the regulatory agencies are reacting to rapid testing methods as alternatives to existing methods.
MA114 Chapter 45 intro to clinical laboratory
This document provides information about the clinical laboratory and the roles of various personnel within it. It discusses:
1) Personnel in the laboratory including pathologists, medical technologists, technicians, and assistants.
2) The use of laboratory testing to obtain diagnostic data alongside a health history and exam.
3) Certifying agencies that regulate laboratory personnel.
4) The role of the clinical laboratory in providing diagnostic tools to physicians.
Dr. Davy Cheng
This document discusses strategies and best practices for adopting medical technology. It emphasizes the importance of health technology assessment (HTA) and knowledge translation (KT) in facilitating evidence-informed decision making. Key challenges include gaps between research evidence and clinical practice. Strategies proposed include creating timely evidence reviews, using frameworks like Know4Go to evaluate technologies based on criteria like effectiveness and costs, and developing institutional capacity for HTA-informed decisions. Local contextualization, collaboration, training, and clinician champions are seen as important for successful technology adoption.
Pressure BioScience Presentation January 2017
This presentation by Pressure BioSciences discusses their Pressure Cycling Technology platform for biological sample preparation. Some key points:
- PCT uses ultra-high pressure to break up cell walls and extract biomolecules, achieving better results than mechanical methods.
- The market for biological sample preparation is multi-billion dollars. PCT addresses the need for improved sample prep methods.
- Over 275 PCT systems have been installed at over 150 customer sites. There are over 100 publications highlighting PCT's advantages.
- Recent accomplishments include a co-marketing agreement with SCIEX, a leader in analytical technologies, and sales of their new Barocycler 2320EXTREME system.
HPV SCREENING & CO TESTING
All the guidelines recommend co testing as the modality of choice for cervical cancer screening.
However, Cobas test was approved by FDA as primary screening modality in 2014.
The paradigm shift – central lab to point of care
This document discusses the journey of laboratory testing from bedside testing to centralized laboratories to point-of-care testing. It provides a brief history of early diagnostic tests and outlines the benefits of point-of-care testing such as simpler sample collection and faster turnaround time. It discusses quality requirements for point-of-care testing devices and the roles of the manufacturer, laboratory, and point-of-care coordinator in ensuring quality. It also addresses challenges of point-of-care testing and the importance of oversight committees.
Syphilis Forum Recap Report
Syphilis Forum Recap Report. Presentation given by Simon Donohoe at the AFAO National Syphilis Forum, 23 October 2009.
Similar to Choosing best laboratory practice (20)
Maintaining quality in molecular Diagnostics final layout
Maintaining quality in molecular Diagnostics final layout
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient results
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
Evidence-Based Clinical Practice Guidelines for OBSTETRICS AND GYNECOLOGY
MODERN REQUIREMENTS OF AN ASSISTED REPRODUCTIVE CENTER OF EXCELLENCE
MODERN REQUIREMENTS OF AN ASSISTED REPRODUCTIVE CENTER OF EXCELLENCE
Colorectal screening evidence & colonoscopy screening guidelines
Colorectal screening evidence & colonoscopy screening guidelines
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Rapid Methodologies for Biosafety Testing of Biologic Therapeutics
Recently uploaded
Letter and Document Automation for Bonterra Impact Management (fka Social Sol...
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on automated letter generation for Bonterra Impact Management using Google Workspace or Microsoft 365.
Interested in deploying letter generation automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
Digital Marketing Trends in 2024 | Guide for Staying Ahead
https://www.wask.co/ebooks/digital-marketing-trends-in-2024
Feeling lost in the digital marketing whirlwind of 2024? Technology is changing, consumer habits are evolving, and staying ahead of the curve feels like a never-ending pursuit. This e-book is your compass. Dive into actionable insights to handle the complexities of modern marketing. From hyper-personalization to the power of user-generated content, learn how to build long-term relationships with your audience and unlock the secrets to success in the ever-shifting digital landscape.
5th LF Energy Power Grid Model Meet-up Slides
5th Power Grid Model Meet-up
It is with great pleasure that we extend to you an invitation to the 5th Power Grid Model Meet-up, scheduled for 6th June 2024. This event will adopt a hybrid format, allowing participants to join us either through an online Mircosoft Teams session or in person at TU/e located at Den Dolech 2, Eindhoven, Netherlands. The meet-up will be hosted by Eindhoven University of Technology (TU/e), a research university specializing in engineering science & technology.
Power Grid Model
The global energy transition is placing new and unprecedented demands on Distribution System Operators (DSOs). Alongside upgrades to grid capacity, processes such as digitization, capacity optimization, and congestion management are becoming vital for delivering reliable services.
Power Grid Model is an open source project from Linux Foundation Energy and provides a calculation engine that is increasingly essential for DSOs. It offers a standards-based foundation enabling real-time power systems analysis, simulations of electrical power grids, and sophisticated what-if analysis. In addition, it enables in-depth studies and analysis of the electrical power grid’s behavior and performance. This comprehensive model incorporates essential factors such as power generation capacity, electrical losses, voltage levels, power flows, and system stability.
Power Grid Model is currently being applied in a wide variety of use cases, including grid planning, expansion, reliability, and congestion studies. It can also help in analyzing the impact of renewable energy integration, assessing the effects of disturbances or faults, and developing strategies for grid control and optimization.
What to expect
For the upcoming meetup we are organizing, we have an exciting lineup of activities planned:
-Insightful presentations covering two practical applications of the Power Grid Model.
-An update on the latest advancements in Power Grid -Model technology during the first and second quarters of 2024.
-An interactive brainstorming session to discuss and propose new feature requests.
-An opportunity to connect with fellow Power Grid Model enthusiasts and users.
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
Simplify your search for a reliable Python development partner! This list presents the top 10 trusted US providers offering comprehensive Python development services, ensuring your project's success from conception to completion.
Operating System Used by Users in day-to-day life.pptx
Dive into the realm of operating systems (OS) with Pravash Chandra Das, a seasoned Digital Forensic Analyst, as your guide. 🚀 This comprehensive presentation illuminates the core concepts, types, and evolution of OS, essential for understanding modern computing landscapes.
Beginning with the foundational definition, Das clarifies the pivotal role of OS as system software orchestrating hardware resources, software applications, and user interactions. Through succinct descriptions, he delineates the diverse types of OS, from single-user, single-task environments like early MS-DOS iterations, to multi-user, multi-tasking systems exemplified by modern Linux distributions.
Crucial components like the kernel and shell are dissected, highlighting their indispensable functions in resource management and user interface interaction. Das elucidates how the kernel acts as the central nervous system, orchestrating process scheduling, memory allocation, and device management. Meanwhile, the shell serves as the gateway for user commands, bridging the gap between human input and machine execution. 💻
The narrative then shifts to a captivating exploration of prominent desktop OSs, Windows, macOS, and Linux. Windows, with its globally ubiquitous presence and user-friendly interface, emerges as a cornerstone in personal computing history. macOS, lauded for its sleek design and seamless integration with Apple's ecosystem, stands as a beacon of stability and creativity. Linux, an open-source marvel, offers unparalleled flexibility and security, revolutionizing the computing landscape. 🖥️
Moving to the realm of mobile devices, Das unravels the dominance of Android and iOS. Android's open-source ethos fosters a vibrant ecosystem of customization and innovation, while iOS boasts a seamless user experience and robust security infrastructure. Meanwhile, discontinued platforms like Symbian and Palm OS evoke nostalgia for their pioneering roles in the smartphone revolution.
The journey concludes with a reflection on the ever-evolving landscape of OS, underscored by the emergence of real-time operating systems (RTOS) and the persistent quest for innovation and efficiency. As technology continues to shape our world, understanding the foundations and evolution of operating systems remains paramount. Join Pravash Chandra Das on this illuminating journey through the heart of computing. 🌟
Generating privacy-protected synthetic data using Secludy and Milvus
During this demo, the founders of Secludy will demonstrate how their system utilizes Milvus to store and manipulate embeddings for generating privacy-protected synthetic data. Their approach not only maintains the confidentiality of the original data but also enhances the utility and scalability of LLMs under privacy constraints. Attendees, including machine learning engineers, data scientists, and data managers, will witness first-hand how Secludy's integration with Milvus empowers organizations to harness the power of LLMs securely and efficiently.
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-und-domino-lizenzkostenreduzierung-in-der-welt-von-dlau/
DLAU und die Lizenzen nach dem CCB- und CCX-Modell sind für viele in der HCL-Community seit letztem Jahr ein heißes Thema. Als Notes- oder Domino-Kunde haben Sie vielleicht mit unerwartet hohen Benutzerzahlen und Lizenzgebühren zu kämpfen. Sie fragen sich vielleicht, wie diese neue Art der Lizenzierung funktioniert und welchen Nutzen sie Ihnen bringt. Vor allem wollen Sie sicherlich Ihr Budget einhalten und Kosten sparen, wo immer möglich. Das verstehen wir und wir möchten Ihnen dabei helfen!
Wir erklären Ihnen, wie Sie häufige Konfigurationsprobleme lösen können, die dazu führen können, dass mehr Benutzer gezählt werden als nötig, und wie Sie überflüssige oder ungenutzte Konten identifizieren und entfernen können, um Geld zu sparen. Es gibt auch einige Ansätze, die zu unnötigen Ausgaben führen können, z. B. wenn ein Personendokument anstelle eines Mail-Ins für geteilte Mailboxen verwendet wird. Wir zeigen Ihnen solche Fälle und deren Lösungen. Und natürlich erklären wir Ihnen das neue Lizenzmodell.
Nehmen Sie an diesem Webinar teil, bei dem HCL-Ambassador Marc Thomas und Gastredner Franz Walder Ihnen diese neue Welt näherbringen. Es vermittelt Ihnen die Tools und das Know-how, um den Überblick zu bewahren. Sie werden in der Lage sein, Ihre Kosten durch eine optimierte Domino-Konfiguration zu reduzieren und auch in Zukunft gering zu halten.
Diese Themen werden behandelt
- Reduzierung der Lizenzkosten durch Auffinden und Beheben von Fehlkonfigurationen und überflüssigen Konten
- Wie funktionieren CCB- und CCX-Lizenzen wirklich?
- Verstehen des DLAU-Tools und wie man es am besten nutzt
- Tipps für häufige Problembereiche, wie z. B. Team-Postfächer, Funktions-/Testbenutzer usw.
- Praxisbeispiele und Best Practices zum sofortigen Umsetzen
Azure API Management to expose backend services securely
How to use Azure API Management to expose backend service securely
HCL Notes and Domino License Cost Reduction in the World of DLAU
Webinar Recording: https://www.panagenda.com/webinars/hcl-notes-and-domino-license-cost-reduction-in-the-world-of-dlau/
The introduction of DLAU and the CCB & CCX licensing model caused quite a stir in the HCL community. As a Notes and Domino customer, you may have faced challenges with unexpected user counts and license costs. You probably have questions on how this new licensing approach works and how to benefit from it. Most importantly, you likely have budget constraints and want to save money where possible. Don’t worry, we can help with all of this!
We’ll show you how to fix common misconfigurations that cause higher-than-expected user counts, and how to identify accounts which you can deactivate to save money. There are also frequent patterns that can cause unnecessary cost, like using a person document instead of a mail-in for shared mailboxes. We’ll provide examples and solutions for those as well. And naturally we’ll explain the new licensing model.
Join HCL Ambassador Marc Thomas in this webinar with a special guest appearance from Franz Walder. It will give you the tools and know-how to stay on top of what is going on with Domino licensing. You will be able lower your cost through an optimized configuration and keep it low going forward.
These topics will be covered
- Reducing license cost by finding and fixing misconfigurations and superfluous accounts
- How do CCB and CCX licenses really work?
- Understanding the DLAU tool and how to best utilize it
- Tips for common problem areas, like team mailboxes, functional/test users, etc
- Practical examples and best practices to implement right away
TrustArc Webinar - 2024 Global Privacy Survey
How does your privacy program stack up against your peers? What challenges are privacy teams tackling and prioritizing in 2024?
In the fifth annual Global Privacy Benchmarks Survey, we asked over 1,800 global privacy professionals and business executives to share their perspectives on the current state of privacy inside and outside of their organizations. This year’s report focused on emerging areas of importance for privacy and compliance professionals, including considerations and implications of Artificial Intelligence (AI) technologies, building brand trust, and different approaches for achieving higher privacy competence scores.
See how organizational priorities and strategic approaches to data security and privacy are evolving around the globe.
This webinar will review:
- The top 10 privacy insights from the fifth annual Global Privacy Benchmarks Survey
- The top challenges for privacy leaders, practitioners, and organizations in 2024
- Key themes to consider in developing and maintaining your privacy program
Fueling AI with Great Data with Airbyte Webinar
This talk will focus on how to collect data from a variety of sources, leveraging this data for RAG and other GenAI use cases, and finally charting your course to productionalization.
Artificial Intelligence for XMLDevelopment
In the rapidly evolving landscape of technologies, XML continues to play a vital role in structuring, storing, and transporting data across diverse systems. The recent advancements in artificial intelligence (AI) present new methodologies for enhancing XML development workflows, introducing efficiency, automation, and intelligent capabilities. This presentation will outline the scope and perspective of utilizing AI in XML development. The potential benefits and the possible pitfalls will be highlighted, providing a balanced view of the subject.
We will explore the capabilities of AI in understanding XML markup languages and autonomously creating structured XML content. Additionally, we will examine the capacity of AI to enrich plain text with appropriate XML markup. Practical examples and methodological guidelines will be provided to elucidate how AI can be effectively prompted to interpret and generate accurate XML markup.
Further emphasis will be placed on the role of AI in developing XSLT, or schemas such as XSD and Schematron. We will address the techniques and strategies adopted to create prompts for generating code, explaining code, or refactoring the code, and the results achieved.
The discussion will extend to how AI can be used to transform XML content. In particular, the focus will be on the use of AI XPath extension functions in XSLT, Schematron, Schematron Quick Fixes, or for XML content refactoring.
The presentation aims to deliver a comprehensive overview of AI usage in XML development, providing attendees with the necessary knowledge to make informed decisions. Whether you’re at the early stages of adopting AI or considering integrating it in advanced XML development, this presentation will cover all levels of expertise.
By highlighting the potential advantages and challenges of integrating AI with XML development tools and languages, the presentation seeks to inspire thoughtful conversation around the future of XML development. We’ll not only delve into the technical aspects of AI-powered XML development but also discuss practical implications and possible future directions.
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift
Overview
Dive into the world of anomaly detection on edge devices with our comprehensive hands-on tutorial. This SlideShare presentation will guide you through the entire process, from data collection and model training to edge deployment and real-time monitoring. Perfect for those looking to implement robust anomaly detection systems on resource-constrained IoT/edge devices.
Key Topics Covered
1. Introduction to Anomaly Detection
- Understand the fundamentals of anomaly detection and its importance in identifying unusual behavior or failures in systems.
2. Understanding Edge (IoT)
- Learn about edge computing and IoT, and how they enable real-time data processing and decision-making at the source.
3. What is ArgoCD?
- Discover ArgoCD, a declarative, GitOps continuous delivery tool for Kubernetes, and its role in deploying applications on edge devices.
4. Deployment Using ArgoCD for Edge Devices
- Step-by-step guide on deploying anomaly detection models on edge devices using ArgoCD.
5. Introduction to Apache Kafka and S3
- Explore Apache Kafka for real-time data streaming and Amazon S3 for scalable storage solutions.
6. Viewing Kafka Messages in the Data Lake
- Learn how to view and analyze Kafka messages stored in a data lake for better insights.
7. What is Prometheus?
- Get to know Prometheus, an open-source monitoring and alerting toolkit, and its application in monitoring edge devices.
8. Monitoring Application Metrics with Prometheus
- Detailed instructions on setting up Prometheus to monitor the performance and health of your anomaly detection system.
9. What is Camel K?
- Introduction to Camel K, a lightweight integration framework built on Apache Camel, designed for Kubernetes.
10. Configuring Camel K Integrations for Data Pipelines
- Learn how to configure Camel K for seamless data pipeline integrations in your anomaly detection workflow.
11. What is a Jupyter Notebook?
- Overview of Jupyter Notebooks, an open-source web application for creating and sharing documents with live code, equations, visualizations, and narrative text.
12. Jupyter Notebooks with Code Examples
- Hands-on examples and code snippets in Jupyter Notebooks to help you implement and test anomaly detection models.
Trusted Execution Environment for Decentralized Process Mining
Presentation of the paper "Trusted Execution Environment for Decentralized Process Mining" given during the CAiSE 2024 Conference in Cyprus on June 7, 2024.
Presentation of the OECD Artificial Intelligence Review of Germany
Consult the full report at https://www.oecd.org/digital/oecd-artificial-intelligence-review-of-germany-609808d6-en.htm
Recently uploaded (20)
Letter and Document Automation for Bonterra Impact Management (fka Social Sol...
Letter and Document Automation for Bonterra Impact Management (fka Social Sol...
Digital Marketing Trends in 2024 | Guide for Staying Ahead
Digital Marketing Trends in 2024 | Guide for Staying Ahead
Overcoming the PLG Trap: Lessons from Canva's Head of Sales & Head of EMEA Da...
Overcoming the PLG Trap: Lessons from Canva's Head of Sales & Head of EMEA Da...
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
Your One-Stop Shop for Python Success: Top 10 US Python Development Providers
Operating System Used by Users in day-to-day life.pptx
Operating System Used by Users in day-to-day life.pptx
Generating privacy-protected synthetic data using Secludy and Milvus
Generating privacy-protected synthetic data using Secludy and Milvus
WeTestAthens: Postman's AI & Automation Techniques
WeTestAthens: Postman's AI & Automation Techniques
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
HCL Notes und Domino Lizenzkostenreduzierung in der Welt von DLAU
Azure API Management to expose backend services securely
Azure API Management to expose backend services securely
HCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAU
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Deep Dive: AI-Powered Marketing to Get More Leads and Customers with HyperGro...
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Monitoring and Managing Anomaly Detection on OpenShift.pdf
Trusted Execution Environment for Decentralized Process Mining
Trusted Execution Environment for Decentralized Process Mining
Presentation of the OECD Artificial Intelligence Review of Germany
Presentation of the OECD Artificial Intelligence Review of Germany
Choosing best laboratory practice
- 1. Choosing Best Laboratory Practice Valerie Bevan Jerry Skinner Ruhi Siddiqui Janet Norcup Sam Gillanders www.HPA.org.uk www.evaluations-standards.org.uk [email_address] standardsunit @HPA.org. uk 14 May 2004
- 5. Office Manager A&C 5 SOP Administrator A&C 5 Information Officer A&C 5 Deputy Director & Head of Quality System Unit CS C Standards Microbiologist BMS 3 Standards Microbiologist BMS 3 SOP/ Quality Systems Administrator A&C 5 Head of Standards Unit/ Accreditation Officer BMS 3+3 Evaluations Microbiologist MTO 3 (MHRA) Evaluations Administrator A&C 6 (MHRA) Evaluations Laboratory Assistant (MHRA) Head of Evaluations Unit CS B19 Quality Control Microbiologist MTO 2 Quality Control Supervisor MTO 3 Head of Quality Control Reagents Unit MTO 5 Laboratory Director Evaluations and Standards Laboratory Evaluation and Standards Laboratory - October 03 Evaluations Microbiologist MTO 3 (NBS) Evaluations Microbiologist MTO 3 (MHRA) Quality Control Microbiologist MTO 2 Quality Control Microbiologist MTO 2 Quality Control Microbiologist MTO 2
- 7. Evaluations Unit Keith Perry Microbiological Diagnostics Assessment Service
- 8. Results: Timing of Detection of Primary HIV Following seroconversion * = combined antigen-antibody = immunometric = Class specific antibody capture = antiglobulin / indirect * based on 38 seroconversion panels
- 9. Quality Control Reagents Unit Joe Vincini – Quality Control Reagents Unit AxSym (Abbott Diagnostics) PRISM(Abbott Diagnostics) Vitros (Ortho Clinical Diagnostics) VIDAS (bioMerieux) ACCESS (Beckman Coulter)
- 13. Technical Adverse Incidents Close liaison with MHRA, companies and users June
- 16. Process Draft SOP SCBM Working Group Standards Unit 1st draft for comment 2nd draft for comment SCBM Working Group Final version
- 18. Need for a broad based approach to health protection 2002
- 19. What network of laboratories? HPA HQ Network of 46 PHLs in 8 Groups CPHL CDSC
- 20. BSOP 28 Investigation of genital tract and associated specimens
- 25. BSOP 28 Investigation of genital tract and associated specimens
- 26. BSOP 28 Investigation of genital tract and associated specimens
- 28. BSOP 28 Investigation of genital tract and associated specimens * Trichomonas media T. vaginalis Clinically suspected TV STD Pregnancy S. aureus Lancefield Groups A, C and G streptococci yeasts N. gonorrhoeae * * * Urethral swab/ Cervical swab S. aureus Lancefield Groups A, C and G streptococci yeasts * * HVS Target organisms GC selective agar Sabouraud agar Blood agar
- 29. BSOP 28 Investigation of genital tract and associated specimens Media used MSOP 5 recommends NYC: GC selective + amphotericin (Nb VCNT + nystatin less effective ) Do you culture HVS or ECX swabs for GC?
- 30. BSOP 28 Investigation of genital tract and associated specimens Which specimen do you examine for Trichomonas vaginalis? We recommend HVS, not ECX
- 31. BSOP 28 Investigation of genital tract and associated specimens How do you process the specimens for TV? We recommend culture but recognise that microscopy/wet prep may be more practical
- 32. BSOP 28 Investigation of genital tract and associated specimens When do you look for anaerobes? We recommend culture depending on clinical details Intra-uterine death Septic abortion Miscarriage Neo FAA agar with with MZ 5ug disc Anaerobes Clinical details Media Target organisms
- 33. BSOP 28 Investigation of genital tract and associated specimens Which specimens do you examine for anaerobes? We recommend culture depending on clinical details
- 34. BSOP 28 Investigation of genital tract and associated specimens Media used for isolating anaerobes We recommend FAA+neomycin (MSOP 4)
- 35. BSOP 28 Investigation of genital tract and associated specimens Do you look for Bacterial vaginosis? 24/47 said ‘Yes’
- 36. BSOP 28 Investigation of genital tract and associated specimens Do you culture and report Group B streptococci from HVS or ECX swabs? We recommend Gp B Strep may be important from either specimen
- 37. BSOP 28 Investigation of genital tract and associated specimens
- 40. Access to HPA SOPs Global access Over 1000 passwords issued for the Extranet site Password requests from 48 countries outside of the UK
Editor's Notes
- Number of issued SOPs Others still in draft
- Number of issued SOPs Others still in draft
- Drafts written by Standards Unit. Food methods different, impractical to employ 1 person just to work on food method – act as co-ordinators for internal recognised food experts. Will explain SMWG in next slide Time – 1 year for completion
- First SOP issued in 1996
- “As for microbiology laboratories, they are under a variety of management arrangements and follow no standard diagnostic criteria in their operations. There is a need to bring consistency to the delivery of public health functions of laboratories and standardise on current good practices” Action proposed: rationalisation of microbiology laboratories and introduction of standards for diagnosis and profiling of micro-organisms
- 82% if GC and NYC taken together
- SOPs used to be controlled paper copies Not flexible enough Now web based
- 7
- PDF only – drafts not displayed nor SOPs under review Laboratories unable to customise them to suit local circumstances
- PDF only – drafts not displayed nor SOPs under review Laboratories unable to customise them to suit local circumstances